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Abstract
Backround: We describe a modified method for deepitheliazation prior to corneal cross linking
(CXL). The technique may overcome the current corneal pachymetric limitation parameter (over
400 microns) that is necessary for the safety of the procedure without affecting the overall benefits.
Methods: In a series of two patients, with inferior topographic steepening and regional thinning
(less than 400 microns corresponding to the area of corneal steepening), CXL after customized
epithelial removal was performed.
Results: There were no intra- or postoperative adverse events seen by the nine month follow up
examination. Stabilization of the corneal ectasia was observed up to nine months post-costumized
pachymetric-guided epithelial removal.
Conclusion:  The technique of customized pachymetric-guided epithelial removal is easy to
perform and may overcome the limitations of the preoperative corneal pachymetry expanding the
application of the procedure in patients with regional corneal thinning.
Background
Corneal ectatic diseases (such as keratoconus and post-
LASIK corneal ectasia) lead to corneal biomechanical
instability, resulting in myopia, irregular astigmatism and
loss of best spectacle corrected visual acuity. Recently, cor-
neal cross linking (CXL) has been introduced, a novel
technique which increases corneal rigidity, improves cor-
neal biomechanics and stabilizes the progression of cor-
neal ectasia [1-6].
Based on the current protocol in performing CXL, the
cross linking effect is limited to the anterior 300 microns
of the corneal stroma [7,8]. Both corneal thickness (over
400 microns) and the presence of riboflavin are of critical
importance to the process since they prevent UVA from
reaching the deep stroma, the endothelium and crystal-
line lens.
The downside of the corneal pachymetry limitation is that
patients with keratoconus or keratectasia often have thin-
ner corneas especially near the apex-cone areas. In order
to overcome this limitation, we performed CXL treatment
in two patients after customized (according to pachymet-
ric measurements) deepitheliazation (preserving the epi-
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thelium in thinner corneal regions where pachymetry was
inadequate-less than 400 microns) and we investigated
the effectiveness and safety of CXL treatment after this
approach.
Methods
Two patients (one with keratoconus and the other with
post LASIK corneal ectasia) with progressive keratectasia
(detected by progressive topographic steepening between
six months consecutive measuerements) and corneal
pachymetry under 400 microns at the area of topographic
steepening (380 and 375 microns determined by ultra-
sound pachymetry) underwent CXL treatment after cus-
tomized epithelial removal. Central corneal pachymetry
were 440 and 435 microns respectively.
The surgical procedure was conducted under sterile condi-
tions. The patient's eye was anesthetized with propa-
racaine 0.5% (Alcaine). A 8.0 mm diameter of corneal
epithelium was mechanically removed using a rotating
brush leaving a small localized inferior area of corneal
epithelium corresponding to the thinner-area (area of
topographic steepening) (Figure 1 and 2a). De-epitheliza-
tion was followed by instillation of riboflavin (0.1% solu-
tion 10 mg riboflavin-5-phosphate) for every 3 minutes
for 15 minutes until the stroma was completely pene-
trated and aqueous was stained yellow. After confirming
presence of riboflavin in the corneal tissue and anterior
chamber (slit lamp biomicroscopy), UVA irradiation was
applied. The UVA irradiation was performed using an
optical system (UV-X illumination system version 1000,
UVXTM, IROC AG, Zurich, Switzerland), with a light
source consisting of an array of UV diodes (365 nm) in
conjunction with a potentiometer to allow regulation of
voltage. Before treatment, an intended 3.0 mW/cm2 of
surface irradiance (5.4 J/cm2 surface dose) was calibrated
using a UV light meter at a working distance of 5 cm. Irra-
diance was performed for 30 minutes at an 8 mm treat-
ment zone. During treatment, riboflavin solution was
applied every 4 minutes to ensure saturation and bal-
anced salt solution (BSS) was used to maintain corneal
stromal hydration (every 35 minutes).
At the end of the procedure, a combination steroid and
antibiotic drop (Tobradex, 4 times daily) was adminis-
tered in all patients and a bandage soft contact lens was
kept in place until full corneal reepithelialization
occurred.
Results
Both procedures were uneventful and no postoperative
complications were demonstrated. The epithelium healed
completely 5 days after the surgery, and the bandage con-
tact lenses were removed. Nine months after the proce-
dures, corneal topography in both patients showed
stability (Figures 2 and 3), while confocal microscopy
analysis demonstrated no endothelial cell density altera-
tions (preoperative were 2512 ± 42 and 2725 ± 102, to
2502 ± 55 and 2738 ± 58 postoperative, respectively).
Discussion
Corneal cross linking with the use of photosynthesizing
riboflavin and UVA has demonstrated satisfactory results
in stabilizing keratoconic and keratectatic corneas. A
major limitation of the technique is that its application is
contraindicated in corneas with stromal pachymetry less
than 400 micrometers. This is due to the fact that an irra-
diance of 0.37 mW/cm2 has been found to be cytotoxic for
the endothelial cell layer. Since the absorption coefficient
for the human corneas is 70 cm-1 and the intended surface
irradiance is 3.0 mW/cm2, the 0.37 mW/cm2irradiance is
reached at 300 microns depth. In a 400 microns thick cor-
nea saturated with riboflavin, the irradiance at the
endothelial level is 0.18 mW/cm2, which is a factor of 2
smaller than the damage threshold. Therefore, the 400
microns limit is considered the safe limit to protect the
endothelium and intraocular structures from the adverse
effects of UV irradiation and it has been established as a
clinical standard [6-8]. Unfortunately, the very patients
who are in need of CXL, those with ectasia, are the same
ones who have thin corneas often below the threshold of
that considered to be safe for CXL treatment.
In order to avoid this limitation, we performed CXL treat-
ment in two patients (thinnest pachymetry of 380 and
375, respectively) after pachymetric-guided corneal epi-
thelial removal, leaving a small localized inferior area of
corneal epithelium corresponding to the thinnest area
Intraoperative pachymetric-guided corneal epithelium  removal during corneal collagen cross linking in patient with  post-LASIK corneal ectasia and inferior corneal thinning Figure 1
Intraoperative pachymetric-guided corneal epithe-
lium removal during corneal collagen cross linking in 
patient with post-LASIK corneal ectasia and inferior 
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over the apex of the cone. The procedure was performed
uneventfully while no adverse effects were found during
the nine month follow up period.
In a recent publication, Hafezi et al [5] report a case of
localized endothelial damage with transient stromal
edema (0.75 mm × 0.75 mm) in the central deep cornea
exactly below the corneal apex, corresponding to the area
of the greatest steepness and corneal thinning. The stro-
mal edema slowly resolved during the following 6 weeks.
The authors suggest increasing stromal thickness to 400
microns by avoiding dehydrating the cornea using an
alternative riboflavin solution without dextran after epi-
thelium debridement. In the technique described in the
current manuscript, we not only prevent local stromal
dehydration by maintaining the epithelium and by using
BSS, but we also, by the preservation of the corneal epithe-
lium, may blocked the excessive UV irradiation in this vul-
nerable area, increasing the safety of the procedure.
During the CXL procedure, the epithelium is removed and
riboflavin solution is placed onto the cornea until it pen-
etrates into the anterior chamber and then UV irradiation
is applied. BSS was used in the current study to maintain
corneal stromal hydration (the current protocol suggests
the use of hypoosolar riboflavin) in between application
of riboflavin solution taking care not to over-dilute the
riboflavin solution which is necessary for cross linking
and protection of the intraocular structures (eg, lens).
Since the cone is denuded of epithelium, it is vulnerable
to excessive dehydration during the lengthy CXL treat-
ment (total of 45 minutes). The selective preservation of
epithelium in our technique may help to minimize the
risk of excess dehydration and inadvertent local damage
to the endothelium in the thinnest areas of the cornea.
Conclusion
In conclusion, localized pachymetric-guided epithelial
removal could increase the safety of the procedure with
localized low pachymetry (under 400 microns) without
adversely affecting the final results of corneal cross link-
ing. Some limitations of this technique are the long term
efficacy of the modified technique, the ability of the epi-
thelium to absorb the UVA radiation (epithelium prefer-
entially absorbs UVB and UVC over UVA radiation) [9],
alterations in riboflavin corneal stromal saturation and
the possibility of partially inadequate treatment in the
areas covered by epithelium. Future comparative studies
Preoperative corneal topography in a patient scheduled for customized pachymetric guided epithelial debridement for corneal  collagen cross linking Figure 2
Preoperative corneal topography in a patient scheduled for customized pachymetric guided epithelial debride-
ment for corneal collagen cross linking.BMC Ophthalmology 2009, 9:10 http://www.biomedcentral.com/1471-2415/9/10
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should be performed in order to elucidate these limita-
tions.
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Last follow up examination corneal topography after customized pachymetric guided epithelial debridement for corneal colla- gen cross linking (from the same patient as in figure 2) Figure 3
Last follow up examination corneal topography after customized pachymetric guided epithelial debridement 
for corneal collagen cross linking (from the same patient as in figure 2).